Exact Mass: 363.1165406
Exact Mass Matches: 363.1165406
Found 414 metabolites which its exact mass value is equals to given mass value 363.1165406
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Dihydrochelirubine
Dihydrochelirubine is a benzophenanthridine alkaloid that is dihydrosanguinarine bearing a methoxy substituent at position 10. It has a role as a metabolite. It is functionally related to a dihydrosanguinarine. Dihydrochelirubine is a natural product found in Eschscholzia californica, Glaucium flavum, and other organisms with data available. A benzophenanthridine alkaloid that is dihydrosanguinarine bearing a methoxy substituent at position 10.
Cefadroxil
C16H17N3O5S (363.08888720000004)
Cefadroxil is only found in individuals that have used or taken this drug. It is a long-acting, broad-spectrum, water-soluble, cephalexin derivative.Like all beta-lactam antibiotics, cefadroxil binds to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, causing the inhibition of the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cefadroxil interferes with an autolysin inhibitor. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic CONFIDENCE standard compound; EAWAG_UCHEM_ID 3662
Rufloxacin
C17H18FN3O3S (363.1052850000001)
Rufloxacin belongs to the family of Phenylpiperazines. These are compounds containing a phenylpiperazine skeleton, which consists of a piperazine bound to a phenyl group. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors Same as: D02474
9-Aminocamptothecin
9-Aminocamptothecin (9-Amino-CPT) is a topoisomerase I inhibitor with potent anticancer activity 9-Aminocamptothecin. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=91421-43-1 (retrieved 2024-08-08) (CAS RN: 91421-43-1). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Benzoximate
C18H18ClNO5 (363.08734480000004)
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007096 - Imidoesters
Methixene hydrochloride
C20H26ClNOS (363.1423536000001)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent
8-Methyldihydrochelerythrine
C22H21NO4 (363.14705060000006)
8-Methyldihydrochelerythrine is found in fruits. 8-Methyldihydrochelerythrine is an alkaloid from root bark of Zanthoxylum simulans (Szechuan pepper). Alkaloid from root bark of Zanthoxylum simulans (Szechuan pepper). 8-Methyldihydrochelerythrine is found in herbs and spices and fruits.
(4-(2-((2-(3-Chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)acetic acid
C19H22ClNO4 (363.1237282000001)
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists
4-[[5-Chloro-4-(2,4,6-trimethylanilino)pyrimidin-2-yl]amino]benzonitrile
9-Aminocamptothecin
7-Methyl-2'-deoxyguanosine-3'-monophosphate
N-Biotinyl-4-aminobenzoic acid
C17H21N3O4S (363.1252706000001)
Biotinyl-p-aminobenzoate
C17H21N3O4S (363.1252706000001)
(2S)-1-[(2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]pyrrolidine-2-carboxylic acid
C16H21N5O5 (363.15426160000004)
Etofibrate
C18H18ClNO5 (363.08734480000004)
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AB - Fibrates D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D009676 - Noxae > D000963 - Antimetabolites
N-((Tetrahydro-5-oxo-2-furanyl)carbonyl)-L-histidyl-L-prolinamide
C16H21N5O5 (363.15426160000004)
2-[[[4-(3-Benzylcyclobutyl)-1,3-thiazol-2-yl]diazenyl]methyl]phenol
C21H21N3OS (363.14052560000005)
Pglu-his-pro
C16H21N5O5 (363.15426160000004)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones Thyrotropin-Releasing Hormone (TRH), Free Acid (TRH-OH) is a physiological metabolite of Thyrotropin-Releasing Hormone.
3-(1,3-Benzodioxol-5-ylmethoxy)-1-chloro-4-(4-fluorophenyl)piperidine
C19H19ClFNO3 (363.10374260000003)
4'-(9-Acridinylamino)methanesulfonanilide
6-Methoxydihydrosanguinarine
9-Aminocamptothecin
9-Aminocamptothecin is a pyranoindolizinoquinoline. Aminocamptothecin has been used in trials studying the treatment of Lymphoma, Gastric Cancer, Ovarian Cancer, Esophageal Cancer, and Ovarian Neoplasms, among others. Aminocamptothecin is a water-insoluble camptothecin derivative. Aminocamptothecin binds to the nuclear enzyme topoisomerase I, thereby inhibiting repair of single-strand DNA breakages. Because the terminal lactone ring of aminocamptothecin required for the agents antitumor activity spontaneously opens under physiological conditions to an inactive carboxy form, the drug must be administered over an extended period of time to achieve effective cytotoxicity. (NCI04) C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor D000970 - Antineoplastic Agents 9-Aminocamptothecin (9-Amino-CPT) is a topoisomerase I inhibitor with potent anticancer activity[1]. 9-Aminocamptothecin. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=91421-43-1 (retrieved 2024-10-18) (CAS RN: 91421-43-1). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
(+)-16-Hydroxy-9-O-demethylgalwesine
C18H21NO7 (363.13179560000003)
FLAMPROP-ISOPROPYL
C19H19ClFNO3 (363.10374260000003)
CONFIDENCE standard compound; INTERNAL_ID 357; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9643; ORIGINAL_PRECURSOR_SCAN_NO 9642 CONFIDENCE standard compound; INTERNAL_ID 357; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9675; ORIGINAL_PRECURSOR_SCAN_NO 9673 CONFIDENCE standard compound; INTERNAL_ID 357; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9699; ORIGINAL_PRECURSOR_SCAN_NO 9697 CONFIDENCE standard compound; INTERNAL_ID 357; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9719; ORIGINAL_PRECURSOR_SCAN_NO 9718 CONFIDENCE standard compound; INTERNAL_ID 357; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9686; ORIGINAL_PRECURSOR_SCAN_NO 9684 DATASET 20200303_ENTACT_RP_MIX505; CONFIDENCE standard compound; INTERNAL_ID 357; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9686; ORIGINAL_PRECURSOR_SCAN_NO 9684 CONFIDENCE standard compound; INTERNAL_ID 357; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9727; ORIGINAL_PRECURSOR_SCAN_NO 9726
2,3,7,8-bismethylenedioxy-11-methoxy-5-methyl-5,6-dihydrodibenzophenanthridine|6-methoxy-13-methyl-13,14-dihydro-[1,3]dioxolo[4,5-i][1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridine|6-methoxydihydrosanguinarine|Dihydrochelirubin|dihydrochelirubine|O-methyl-11,12,13,14-tetradehydro-chelidonine
(13-methyl-13,14-dihydro-[1,3]dioxolo[4,5-i][1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin-6-yl)-methanol|6-hydroxymethyl-dihydro-sanguinarine|8-hydroxymethyl dihydrosanguinarine|8-Hydroxymethyldihydrosanguinarine
(-)-7-bromohomotrypargine
A natural product found in Pseudodistoma opacum.
alpha-Hydroxyorcein
A member of the class of phenoxazines that is 1,9-dimethyl-3H-phenoxazin-3-one carrying additional hydroxy and 2,4-dihydroxy-6-methylphenyl substituents at positions 7 and 8 respectively. A component of orcein, a mixture of dyes isolated from lichens.
glioperazine B
C17H21N3O4S (363.1252706000001)
A member of the class of 2,5-diketopiperazines with an indole substituent. It is a microbial metabolite isolated from the mycelia of a liquid fermentation culture of the fungus, Bionectria byssicola and has been shown to exhibit antibacterial activity against Staphylococcus aureus.
(R)-2-(6-O-trans-2-butenoyl-beta-D-glucopyranosyloxy)-phenylacetonitrile
C18H21NO7 (363.13179560000003)
N-acetyl-9-O-lactoyl-2-deoxy-2,3-didehydroneuraminic acid
CAY10581
C22H21NO4 (363.14705060000006)
6-Methoxydihydroavicine
6-Methoxy Dihydrosanguinarine is a natural product found in Corydalis balansae and Chelidonium majus with data available.
Naloxone HCl
C19H22ClNO4 (363.1237282000001)
D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist Naloxone hydrochloride is an antagonist of Opioid receptor. Naloxone hydrochloride alleviates opioid-overdose-induced respiratory depression. Naloxone hydrochloride may cause pulmonary edema and cardiac arrhythmias[1].
C21H21N3O3_8,8-Dimethyl-5a,6-dihydro-3H,5H,8H-spiro[indole-2,7-pyrrolo[1,2:4,5]pyrazino[1,2-a]azepine]-3,5,12(1H,2H)-trione
Rufloxacin
C17H18FN3O3S (363.1052850000001)
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors Same as: D02474
L-gamma-Glutamyl-S-3-(1-oxopropyl)-L-cysteinyl-glycine
This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 16HP2005 to the Mass Spectrometry Society of Japan.
topramezone
C16H17N3O5S (363.08888720000004)
CONFIDENCE standard compound; INTERNAL_ID 460; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3178; ORIGINAL_PRECURSOR_SCAN_NO 3177 CONFIDENCE standard compound; INTERNAL_ID 460; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3195; ORIGINAL_PRECURSOR_SCAN_NO 3193 CONFIDENCE standard compound; INTERNAL_ID 460; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3168; ORIGINAL_PRECURSOR_SCAN_NO 3166 CONFIDENCE standard compound; INTERNAL_ID 460; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3180; ORIGINAL_PRECURSOR_SCAN_NO 3179 CONFIDENCE standard compound; INTERNAL_ID 460; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3178; ORIGINAL_PRECURSOR_SCAN_NO 3176 CONFIDENCE standard compound; INTERNAL_ID 460; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3179; ORIGINAL_PRECURSOR_SCAN_NO 3177
Ala Cys Gly Asn
C12H21N5O6S (363.12124860000006)
Ala Cys Asn Gly
C12H21N5O6S (363.12124860000006)
Ala Gly Cys Asn
C12H21N5O6S (363.12124860000006)
Ala Gly Asn Cys
C12H21N5O6S (363.12124860000006)
Ala Asn Cys Gly
C12H21N5O6S (363.12124860000006)
Ala Asn Gly Cys
C12H21N5O6S (363.12124860000006)
Cys Ala Gly Asn
C12H21N5O6S (363.12124860000006)
Cys Ala Asn Gly
C12H21N5O6S (363.12124860000006)
Cys Gly Ala Asn
C12H21N5O6S (363.12124860000006)
Cys Gly Gly Lys
C13H25N5O5S (363.15763200000004)
Cys Gly Gly Gln
C12H21N5O6S (363.12124860000006)
Cys Gly Lys Gly
C13H25N5O5S (363.15763200000004)
Cys Gly Asn Ala
C12H21N5O6S (363.12124860000006)
Cys Gly Gln Gly
C12H21N5O6S (363.12124860000006)
Cys Lys Gly Gly
C13H25N5O5S (363.15763200000004)
Cys Asn Ala Gly
C12H21N5O6S (363.12124860000006)
Cys Asn Gly Ala
C12H21N5O6S (363.12124860000006)
Cys Gln Gly Gly
C12H21N5O6S (363.12124860000006)
Gly Ala Cys Asn
C12H21N5O6S (363.12124860000006)
Gly Ala Asn Cys
C12H21N5O6S (363.12124860000006)
Gly Cys Ala Asn
C12H21N5O6S (363.12124860000006)
Gly Cys Gly Lys
C13H25N5O5S (363.15763200000004)
Gly Cys Gly Gln
C12H21N5O6S (363.12124860000006)
Gly Cys Lys Gly
C13H25N5O5S (363.15763200000004)
Gly Cys Asn Ala
C12H21N5O6S (363.12124860000006)
Gly Cys Gln Gly
C12H21N5O6S (363.12124860000006)
Gly Gly Cys Lys
C13H25N5O5S (363.15763200000004)
Gly Gly Cys Gln
C12H21N5O6S (363.12124860000006)
Gly Gly Lys Cys
C13H25N5O5S (363.15763200000004)
Gly Gly Gln Cys
C12H21N5O6S (363.12124860000006)
Gly Lys Cys Gly
C13H25N5O5S (363.15763200000004)
Gly Lys Gly Cys
C13H25N5O5S (363.15763200000004)
Gly Asn Ala Cys
C12H21N5O6S (363.12124860000006)
Gly Asn Cys Ala
C12H21N5O6S (363.12124860000006)
Gly Asn Ser Ser
Gly Gln Cys Gly
C12H21N5O6S (363.12124860000006)
Gly Gln Gly Cys
C12H21N5O6S (363.12124860000006)
Gly Ser Asn Ser
Gly Ser Ser Asn
Lys Cys Gly Gly
C13H25N5O5S (363.15763200000004)
Lys Gly Cys Gly
C13H25N5O5S (363.15763200000004)
Lys Gly Gly Cys
C13H25N5O5S (363.15763200000004)
Asn Ala Cys Gly
C12H21N5O6S (363.12124860000006)
Asn Ala Gly Cys
C12H21N5O6S (363.12124860000006)
Asn Cys Ala Gly
C12H21N5O6S (363.12124860000006)
Asn Cys Gly Ala
C12H21N5O6S (363.12124860000006)
Asn Gly Ala Cys
C12H21N5O6S (363.12124860000006)
Asn Gly Cys Ala
C12H21N5O6S (363.12124860000006)
Asn Gly Ser Ser
Asn Ser Gly Ser
Asn Ser Ser Gly
Gln Cys Gly Gly
C12H21N5O6S (363.12124860000006)
Gln Gly Cys Gly
C12H21N5O6S (363.12124860000006)
Gln Gly Gly Cys
C12H21N5O6S (363.12124860000006)
Ser Gly Asn Ser
Ser Gly Ser Asn
Ser Asn Gly Ser
Ser Asn Ser Gly
Ser Ser Gly Asn
Ser Ser Asn Gly
GSK264220A
C17H21N3O4S (363.1252706000001)
8-Methyldihydrochelerythrine
C22H21NO4 (363.14705060000006)
Serabelisib
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor D004791 - Enzyme Inhibitors
Broperamole
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
AMINO-(3,4-DIBENZYLOXY-PHENYL)-ACETIC ACID
C22H21NO4 (363.14705060000006)
2-(METHYLSULFANYL)[1,3]OXAZOLO[4,5-B]PYRIDINE
C22H21NO4 (363.14705060000006)
5-NITRO-2-(4-NITROPHENYL)BENZANILIDE
C19H13N3O5 (363.08551680000005)
Thiazolidine, 3-[(4-ethoxyphenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)
1-FMOC-4-CARBOXYMETHYLENE-PIPERIDINE
C22H21NO4 (363.14705060000006)
LOXITANE C
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist
B-Paba
C17H21N3O4S (363.1252706000001)
3-HYDROXY-2,3-DIMETHYLBUTAN-2-YL HYDROGEN (3-((1,3-DIOXOISOINDOLIN-2-YL)METHYL)PHENYL)BORONATE
C21H22BNO4 (363.16418020000003)
tert-Butyl 6-bromospiro[indene-1,4-piperidine]-1-carboxylate
benzyl 2-amino-5-methoxy-4-phenylmethoxybenzoate
C22H21NO4 (363.14705060000006)
benzyl N-[6-oxo-1-(2-oxoethyl)-2-phenylpyrimidin-5-yl]carbamate
(2-PHTALIMIDOMETHYLPHENYL)BORONIC ACID, PINACOL ESTER
C21H22BNO4 (363.16418020000003)
Urea, N-[2-[(3-cyano-8-methyl-2-quinolinyl)amino]ethyl]-N-(4-fluorophenyl)- (9CI)
C20H18FN5O (363.14953099999997)
Urea, N-[2-[(3-cyano-8-methyl-2-quinolinyl)amino]ethyl]-N-(2-fluorophenyl)- (9CI)
C20H18FN5O (363.14953099999997)
4-(4-BENZYLPIPERAZINO)-1H-INDOLE DIHYDROCHLORIDE MONOHYDRATE
2-amino-6-(3-chlorophenyl)-5-methyl-3-nitro-4-phenylbenzonitrile
C20H14ClN3O2 (363.07744940000003)
[2-(dimethylamino)-2-methylpropyl] 2-hydroxy-2,2-diphenylacetate,hydrochloride
C20H26ClNO3 (363.16011160000005)
(4-PHTHALIMIDOMETHYLPHENYL)BORONIC ACID, PINACOL ESTER
C21H22BNO4 (363.16418020000003)
[4-(Carbazol-9-yl)-1,1-biphenyl-4-yl]boronic acid
C24H18BNO2 (363.14305179999997)
N-(2,5-Dimethoxyphenyl)-2-hydroxydibenzofuran-3-carboxamide
8-Amino-4-ethyl-4-hydroxy-1H-pyrano[3,4:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
(6,9-Diphenyl-9H-carbazol-3-yl)boronic acid
C24H18BNO2 (363.14305179999997)
Efaproxiral sodium
C20H22NNaO4 (363.14464520000007)
C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent
3H-Xanthen-3-one,9-[4-(dimethylamino)phenyl]-2,6,7-trihydroxy-
Dibenzyl L-glutamate hydrochloride
C19H22ClNO4 (363.1237282000001)
n-methoxy-n-methyl(triphenyl-phosphoranylidene)acetamide
4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophene-7-carbaldehyde
Methacrylic acid, 2-hydroxyethyl ester diphenyl phosphate
C18H20O6P (363.09974500000004)
1-[2-(4-(Trifluoromethyl)phenyl)ethyl]-6,7-dimethoxy-3,4-dihydroisoquinoline
C20H20F3NO2 (363.14460560000003)
1,2,3,4-Tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid phenylmethyl ester hydrochloride
C19H22ClNO4 (363.1237282000001)
Trimethyl[2-[(trimethylsilyl)methyl]benzyl]ammonium Iodide
Methyl 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carb oxylate
C20H14ClN3O2 (363.07744940000003)
Ozenoxacin
D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D004791 - Enzyme Inhibitors
(4-(N-ISOPROPYL-N-(4-METHOXYBENZYL)SULFAMOYL)PHENYL)BORONIC ACID
C17H22BNO5S (363.13116720000005)
isopropyl N-benzoyl-N-(3-chloro-4-fluorophenyl)-L-alaninate
C19H19ClFNO3 (363.10374260000003)
Thiphenamil hydrochloride
C20H26ClNOS (363.1423536000001)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
antazoline
C17H22N3O4P (363.13478620000006)
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents
9-(Biphenyl-4-yl)carbazole-2-boronic acid
C24H18BNO2 (363.14305179999997)
7,8-diethoxy-4-oxo-4H-benzo[4,5]thiazolo[3,2-a]pyrimidine-3-carboxylic acid ethyl ester
C16H17N3O5S (363.08888720000004)
GLY-PRO 4-METHOXY-BETA-NAPHTHYLAMIDE HYDROCHLORIDE
4-[(5,6-DIHYDRO[2,3-BIPYRIDIN]-3(4H)-YLIDENE)METHYL]-N,N-DIMETHYLBENZENAMINE DIHYDROCHLORIDE
(3-(N-Isopropyl-N-(4-methoxybenzyl)sulfamoyl)phenyl)boronic acid
C17H22BNO5S (363.13116720000005)
[[(1R)-2-(6-aMino-9H-purin-9-yl)-1-Methylethoxy]Methyl]-, Monophenylester
C15H18N5O4P (363.10963580000004)
l-d-(a-Aminoadipoyl)-l-cysteinyl-d-valine
C14H25N3O6S (363.14639900000003)
Zacopride HCl
C15H23Cl2N3O3 (363.11163880000004)
C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent
(3-Chloro-2,6-dimethoxyphenyl)(ethoxyimino)methyl benzoate
C18H18ClNO5 (363.08734480000004)
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007096 - Imidoesters
2-(4-((2R)-2-(((2R)-2-(3-Chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)acetic acid
C19H22ClNO4 (363.1237282000001)
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists
N-(4-chloroanilino)-N-(4-chlorophenyl)-3,3-dimethyl-2-oxobutanimidamide
2-[4-(1-adamantyl)-N-methylsulfonylanilino]acetic acid
C19H25NO4S (363.15042100000005)
Protuboxepin B
An organic heterotricyclic compound that is 10,11-dihydro-6H-oxepino[2,3-d]pyrazino[1,2-a]pyrimidine-6,9(8H)-dione substituted by a benzyl group at position 8 and an isopropyl group at position 11. It has been isolated from Aspergillus species.
3-(1-azepanylsulfonyl)-N-(3-isoxazolyl)-4-methylbenzamide
C17H21N3O4S (363.1252706000001)
2-[(4-Phenylphenyl)sulfonylamino]pentanedioic acid
C17H17NO6S (363.07765420000004)
(6R,7R)-7-[[2-amino-2-(4-hydroxyphenyl)-1-oxoethyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
C16H17N3O5S (363.08888720000004)
4-Chloro-1-naphthyl 5-methoxy-2-(2-pyridinyl)-4-pyrimidinyl ether
C20H14ClN3O2 (363.07744940000003)
2-[(4-amino-5-cyclohexyl-1,2,4-triazol-3-yl)thio]-N-(3-fluoro-4-methylphenyl)acetamide
{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone
C22H21NO2S (363.12929260000004)
(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime
C20H18FN5O (363.14953099999997)
[n-(Benzyloxycarbonyl)amino](4-amidinophenyl)methane-phosphonate
C16H18N3O5P (363.09840280000003)
Etofibrate
C18H18ClNO5 (363.08734480000004)
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AB - Fibrates D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D009676 - Noxae > D000963 - Antimetabolites
(2S)-1-[(2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]pyrrolidine-2-carboxylic acid
C16H21N5O5 (363.15426160000004)
N-Acetylphosphinothricin tripeptide
C13H22N3O7P-2 (363.11953120000004)
3-[[(E)-4-Methoxy-4-oxo-2-butenoyl]amino]-L-Ala-L-Phe-OH
C17H21N3O6 (363.14302860000004)
(1R,2R,5S,8S,9S,10R,11R,12R,13S)-5,12,13-trihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate
N-acetyl-alpha-D-muramoyl-L-alaninate
C14H23N2O9- (363.14034879999997)
The carbohydrate acid derivative anion formed by loss of a proton from the carboxy group of N-acetyl-alpha-D-muramoyl-L-alanine; principal microspecies at pH 7.3.
N-(4,6-dimethylpyrimidin-2-yl)-N-(2-methoxycarbonylphenyl)sulfonylcarbamimidate
C15H15N4O5S- (363.07631200000003)
3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanyl-L-phenylalanine
C17H21N3O6 (363.14302860000004)
5-(2-Oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoyl 4-aminobenzoate
C17H21N3O4S (363.1252706000001)
6-(1,3-benzodioxol-5-yl)-N-(3-oxanylmethyl)-4-quinazolinamine
2-[(2-methyl-4-benzofuro[3,2-d]pyrimidinyl)thio]-N-(phenylmethyl)acetamide
(9S,11R)-12,12-dimethylspiro[1,7-diazatricyclo[7.5.0.03,7]tetradeca-3,13-diene-11,2-1H-indole]-2,3,8-trione
phe-FMDP
C17H21N3O6 (363.14302860000004)
A dipeptide composed of 3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanine and L-phenylalanine joined by peptide linkages.
10-(4-methoxyphenyl)-2-methyl-8,9-dihydro-3H-cyclopenta[5,6]pyrido[3,2:4,5]thieno[3,2-d]pyrimidin-4(7H)-one
N-(6-acetyl-1,3-benzodioxol-5-yl)-5-methyl-2-phenyl-3-pyrazolecarboxamide
2,4,5-trimethoxy-N-(2-phenylphenyl)benzamide
C22H21NO4 (363.14705060000006)
4-chloro-N-(2-methoxy-1-phenazinyl)benzamide
C20H14ClN3O2 (363.07744940000003)
Benzoic acid [2-oxo-2-[2-(phenylthio)anilino]ethyl] ester
N-(3,4-dimethoxyphenyl)-6-phenyl-4-thieno[2,3-d]pyrimidinamine
4-[(2-Hydroxyanilino)methylidene]-2-(2-thiazolyl)isoquinoline-1,3-dione
C19H13N3O3S (363.0677588000001)
7-[(3-hydroxy-3,4-dihydro-2H-benzo[h]quinolin-1-yl)methyl]-5-thiazolo[3,2-a]pyrimidinone
N-(2-methoxy-5-methylphenyl)-3-(4-methoxyphenyl)sulfonylpropanamide
1H-indazole-3-carboxylic acid 4-(1,3-dioxo-2-isoindolyl)butyl ester
2-[[2-[1-(2-methoxyethyl)-2,5-dimethyl-3-pyrrolyl]-2-oxoethyl]thio]-6-propyl-1H-pyrimidin-4-one
4-[3-(1,3-Dioxo-2-isoindolyl)propylamino]-2-methylisoindole-1,3-dione
6-[[[1-(4-chlorophenyl)-5-tetrazolyl]thio]methyl]-N2,N2-dimethyl-1,3,5-triazine-2,4-diamine
1-(4-Chlorophenyl)-5-[1-(2-oxolanylmethylamino)ethylidene]-1,3-diazinane-2,4,6-trione
C17H18ClN3O4 (363.09857780000004)
2-[(1-Amino-1-oxopropan-2-yl)thio]-3-butyl-4-oxo-7-quinazolinecarboxylic acid methyl ester
C17H21N3O4S (363.1252706000001)
(1,2-Dimethyl-3-imidazo[1,2-a]pyridin-4-iumyl)-diphenyl-sulfanylidenephosphorane
C21H20N2PS+ (363.10847500000006)
5-[2-(1-Cyclohexenyl)ethylsulfamoyl]-3-methyl-2-benzofurancarboxylic acid
1-(4,6-dimethoxy-1,3,5-triazin-2-yl)-N-(thiophen-2-ylmethyl)-4-piperidinecarboxamide
C16H21N5O3S (363.1365036000001)
3-[[4-(1,3,4-Oxadiazol-2-yl)phenyl]methyl]-2lambda6-thia-3-azatricyclo[6.3.1.04,12]dodeca-1(11),4,6,8(12),9-pentaene 2,2-dioxide
C19H13N3O3S (363.0677588000001)
3-[[4-[(4-chlorophenyl)methyl]-4-(hydroxymethyl)-1-piperidinyl]-oxomethyl]-4,5-dihydro-1H-pyridazin-6-one
1-[(E)-1-[4-(Difluoromethoxy)phenyl]ethylideneamino]-3-(2,6-dimethylphenyl)thiourea
C18H19F2N3OS (363.12168280000003)
N-[(E)-(5-Morpholin-4-ylthiophen-2-yl)methylideneamino]-N-phenylaniline
C21H21N3OS (363.14052560000005)
N-[[(2S)-3beta-(Ethoxycarbonyl)aziridine-2alpha-yl]carbonyl]-Gly-Gly-OBzl
C17H21N3O6 (363.14302860000004)
6-(1,3-benzodioxol-5-yl)-N-(2-oxanylmethyl)-4-quinazolinamine
2-[(3R,4S)-3-[[5-(methoxymethyl)-1,2-oxazol-3-yl]methyl]piperidin-4-yl]-N-(thiophen-2-ylmethyl)acetamide
2-[[2-(3-chloro-4-fluoroanilino)-2-oxoethyl]-methylamino]-N-(4-methylphenyl)acetamide
hydron;1-methyl-3-(9H-thioxanthen-9-ylmethyl)piperidine;chloride;hydrate
C20H26ClNOS (363.1423536000001)
[(1-amino-2-naphthalen-1-ylethylidene)amino] N-(2-ethoxyphenyl)carbamate
3-(4-Morpholinyl)-2-phenyl-1-[4-(trifluoromethyl)phenyl]-1-propanone
C20H20F3NO2 (363.14460560000003)
(4R)-2-[2-[(S)-amino-(4-hydroxyphenyl)methyl]-5-hydroxy-1,3-oxazol-4-yl]-5,5-dimethyl-4H-1,3-thiazole-4-carboxylic acid
C16H17N3O5S (363.08888720000004)
9-(4-Fluorophenyl)-2-(4-methoxyphenyl)purine-6-carboxamide
2-N-[(1S)-1-(3,5-dichlorophenyl)ethyl]-2-N-methylpyrimido[4,5-d]pyrimidine-2,5,7-triamine
Cefadroxil
C16H17N3O5S (363.08888720000004)
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins A cephalosporin bearing methyl and (2R)-2-amino-2-(4-hydroxyphenyl)acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
E1231
E1231 is an orally active activator of Sirtuin 1 (SIRT1) (EC50=0.83 μM), to modulate cholesterol and lipid metabolism. E1231 interactes with SIRT1 (KD=9.61 μM) and deacetylated liver X receptor-alpha (LXRα), and increases ATP-binding cassette transporter A1 (ABCA1) expression. E1231 also reduces atherosclerotic plaque development in ApoE-/- mice model. E1231 can be used for research in cholesterol and lipid disorder-related diseases[1]. E1231 is an orally active activator of Sirtuin 1 (SIRT1) (EC50=0.83 μM), to modulate cholesterol and lipid metabolism. E1231 interactes with SIRT1 (KD=9.61 μM) and deacetylated liver X receptor-alpha (LXRα), and increases ATP-binding cassette transporter A1 (ABCA1) expression. E1231 also reduces atherosclerotic plaque development in ApoE-/- mice model. E1231 can be used for research in cholesterol and lipid disorder-related diseases[1].
SCD1 inhibitor-4
SCD1 inhibitor-4 is a potent, orally active stearoylCoA desaturase-1 (SCD1) inhibitor. SCD1 inhibitor-4 can be used for the research of diabetes[1].
9-hydroxy-4-methoxy-10-methyl-11-(3-methylbut-2-en-1-yl)furo[3,2-b]acridin-5-one
C22H21NO4 (363.14705060000006)
2-hydroxy-6'-(2-methylprop-1-en-1-yl)-1',7'-diazaspiro[indole-3,5'-tricyclo[7.3.0.0³,⁷]dodecan]-3'-ene-2',8'-dione
2-amino-3-[(triphenylmethyl)sulfanyl]propanoic acid
C22H21NO2S (363.12929260000004)
(2s,4s,5s,6s)-4,5-dihydroxy-6-[3-(c-hydroxycarbonimidoylmethyl)-4-methoxyindol-1-yl]oxane-2-carboximidic acid
C17H21N3O6 (363.14302860000004)
1-[(12s)-18-acetyl-13-methyl-5,7-dioxa-13-azapentacyclo[10.7.1.0²,¹⁰.0⁴,⁸.0¹⁶,²⁰]icosa-1(19),2,4(8),9,16(20),17-hexaen-19-yl]ethanone
C22H21NO4 (363.14705060000006)
(2s)-2-amino-5-{[(1r)-1-{[(1r)-1-carboxy-2-methylpropyl]-c-hydroxycarbonimidoyl}-2-sulfanylethyl]-c-hydroxycarbonimidoyl}pentanoic acid
C14H25N3O6S (363.14639900000003)
3-benzyl-1-hydroxy-4-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}pyrrole-2,5-dione
C22H21NO4 (363.14705060000006)
11-methoxy-12-methyl-5,7,17,19-tetraoxa-12-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁶,²⁰]tetracosa-1(13),2,4(8),9,14,16(20),21,23-octaene
n-{4-[(1s)-7-bromo-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]butyl}guanidine
(2s)-2-({hydroxy[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]methylidene}amino)-6-[(hydroxymethylidene)amino]hexanoic acid
C17H21N3O6 (363.14302860000004)
5-hydroxy-6-[(4-hydroxyphenyl)methyl]-3-(1h-indol-3-ylmethyl)-1-methyl-3,6-dihydropyrazin-2-one
(2r,5r,6r,6as)-5-(6-aminopurin-9-yl)-2-(carboxymethyl)-6-hydroxy-5h,6h,6ah-furo[3,2-b]furan-2-carboxylic acid
C14H13N5O7 (363.08149480000003)
n-{2-[11-(methylsulfanyl)-12-oxo-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-10-yl]ethyl}ethanimidic acid
(2s,3s,4'r)-4'-(acetyloxy)-1'-methoxy-5'-methylidene-2'-oxo-3-[(1e)-prop-1-en-1-yl]-7-oxaspiro[bicyclo[2.2.1]heptane-2,3'-pyrrolidin]-5-en-6-yl acetate
C18H21NO7 (363.13179560000003)